ARDELYX, INC. Capital Expenditures Incurred but Not yet Paid
ARDELYX, INC. (ARDX) reported Capital Expenditures Incurred but Not yet Paid of $55.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2020-03-06
- ARDELYX, INC. capital expenditures incurred but not yet paid for the quarter ending 2016-12-31 was -$324.00K.
- ARDELYX, INC. capital expenditures incurred but not yet paid for the quarter ending 2016-09-30 was $802.00K.
- ARDELYX, INC. capital expenditures incurred but not yet paid for the quarter ending 2016-06-30 was $236.00K.
- ARDELYX, INC. capital expenditures incurred but not yet paid for the quarter ending 2016-03-31 was $16.00K, a 93.16% decline year-over-year.
- ARDELYX, INC. capital expenditures incurred but not yet paid for fiscal 2017 was $55.00K, a 92.47% decline from fiscal 2016.
- ARDELYX, INC. capital expenditures incurred but not yet paid for fiscal 2016 was $730.00K.
- ARDELYX, INC. capital expenditures incurred but not yet paid for fiscal 2015 was $0.00.
- ARDELYX, INC. capital expenditures incurred but not yet paid for fiscal 2014 was $0.00.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2017-12-31 | $55.00K 10-K · filed 2020-03-06 | |||
| 2016-12-31 | -$324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $478.00K derived: sum of 2 quarters · filed 2019-03-06 | $714.00K derived: sum of 3 quarters · filed 2019-03-06 | $730.00K 10-K · filed 2019-03-06 |
| 2016-09-30 | $802.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $1.04M derived: sum of 2 quarters · filed 2016-11-07 | $1.05M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $252.00K 10-Q · filed 2016-08-08 | ||
| 2016-03-31 | $16.00K 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-03-04 | |||
| 2015-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $134.00K 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $234.00K 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-03-04 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |